Revolution Medicines, Inc.
RVMD- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001628171
In the last 90 days, Revolution Medicines, Inc. insiders filed 0 open-market purchases and 18 sales; 693 institutions reported holding it in 13F filings for Q2 2026, worth $40.1B in total; Duquesne Family Office is the only superinvestor holding it.
Other share classesRVMDW
13F holders, Q1 2026
Institutional positions in Revolution Medicines, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 514
- +134 vs. Q4 2025
- Shares held
- 198.3M
- +18.1M (+10.1%) vs. Q4 2025
- Total value
- $19.1B
- +$4.71B (+32.9%) vs. Q4 2025
- New holders
- 172
- 165 more added
- Sold out
- 38
- 127 more reduced
7 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVMD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 693 | $40.1B |
| Q1 2026 | 514 | $19.1B |
| Q4 2025 | 387 | $15.9B |
| Q3 2025 | 323 | $8.96B |
| Q2 2025 | 308 | $7.02B |
| Q1 2025 | 284 | $6.83B |
| Q4 2024 | 281 | $8.45B |
| Q3 2024 | 255 | $7.74B |
| Q2 2024 | 223 | $6.54B |
| Q1 2024 | 210 | $5.18B |
| Q4 2023 | 184 | $4.59B |
| Q3 2023 | 168 | $3.11B |
| Q2 2023 | 139 | $2.99B |
| Q1 2023 | 152 | $2.34B |
| Q4 2022 | 135 | $2.10B |
| Q3 2022 | 142 | $1.74B |
| Q2 2022 | 135 | $1.49B |
| Q1 2022 | 126 | $1.89B |
| Q4 2021 | 117 | $1.85B |
| Q3 2021 | 114 | $1.99B |
| Q2 2021 | 130 | $2.23B |
| Q1 2021 | 128 | $3.05B |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Revolution Medicines, Inc.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 3,338,142 | $323.9M | 0.02% | +176,179+5.6% | Added |
| UBS Group AG | 4,386,791 | $426.6M | 0.08% | +1,298,854+42.1% | Added |
| State Street Corp | 4,402,662 | $428.2M | 0.01% | +293,372+7.1% | Added |
| Adage Capital Partners GP, L.L.C. | 5,475,611 | $532.5M | 0.82% | +3,270,056+148.3% | Added |
| Wellington Management Group LLP | 6,027,819 | $586.2M | 0.11% | −959,820−13.7% | Reduced |
| Paradigm Biocapital Advisors LP | 6,655,703 | $647.3M | 13.23% | +11,300+0.2% | Added |
| Vanguard Portfolio Management LLC | 7,502,623 | $729.6M | 0.04% | +7,502,623 | New |
| Nextech Invest, Ltd. | 7,601,087 | $739.2M | 52.02% | 00.0% | Unchanged |
| Vanguard Capital Management LLC | 8,362,284 | $813.2M | 0.02% | +8,362,284 | New |
| FMR LLC | 8,464,314 | $823.2M | 0.04% | −123,667−1.4% | Reduced |
| Baker Bros. Advisors LP | 9,555,357 | $929.3M | 5.34% | +100,000+1.1% | Added |
| Janus Henderson Group PLC | 9,766,496 | $949.5M | 0.45% | −2,537,006−20.6% | Reduced |
| BlackRock, Inc. | 11,212,706 | $1.09B | 0.02% | +2,286,050+25.6% | Added |
| Farallon Capital Management, L.L.C. | 13,604,796 | $1.32B | 7.84% | −978,000−6.7% | Reduced |
| Hood River Capital Management LLC | 0 | $0 | 0.00% | −945,585−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −446,616−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −287,646−100.0% | Sold out |
| NEOS Investment Management LLC | 0 | $0 | 0.00% | −101,888−100.0% | Sold out |
| Superstring Capital Management LP | 0 | $0 | 0.00% | −54,879−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −40,145−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −33,537−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −21,076−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −20,664−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −15,640−100.0% | Sold out |
| Neo Ivy Capital Management | 0 | $0 | 0.00% | −13,498−100.0% | Sold out |
| Knights of Columbus Asset Advisors LLC | 0 | $0 | 0.00% | −12,114−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −11,192−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −10,179−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −9,644−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −8,129−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −6,939−100.0% | Sold out |
| PSP Research LLC | 0 | $0 | 0.00% | −6,872−100.0% | Sold out |
| VARCOV Co. | 0 | $0 | 0.00% | −6,532−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −6,391−100.0% | Sold out |
| StepStone Group LP | 0 | $0 | 0.00% | −5,971−100.0% | Sold out |
| Fishman Jay A Ltd | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Forum Financial Management, LP | 0 | $0 | 0.00% | −4,982−100.0% | Sold out |
| National Asset Management, Inc. | 0 | $0 | 0.00% | −4,754−100.0% | Sold out |
| Baader Bank INC | 0 | $0 | 0.00% | −4,000−100.0% | Sold out |
| Virginia Retirement Systems Et Al | 0 | $0 | 0.00% | −3,900−100.0% | Sold out |
| Temasek Holdings (Private) Ltd | 0 | $0 | 0.00% | −3,148−100.0% | Sold out |
| Avanza Fonder AB | 0 | $0 | 0.00% | −3,036−100.0% | Sold out |
| Yousif Capital Management, LLC | 0 | $0 | 0.00% | −1,994−100.0% | Sold out |
| Voleon Capital Management LP | 0 | $0 | 0.00% | −2,785−100.0% | Sold out |
| Wealth Enhancement Advisory Services, LLC | 0 | $0 | 0.00% | −2,604−100.0% | Sold out |
| JGP Global Gestao de Recursos Ltda. | 0 | $0 | 0.00% | −2,545−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −2,397−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| SageView Advisory Group, LLC | 0 | $0 | 0.00% | −190−100.0% | Sold out |
| Kayne Anderson Rudnick Investment Management LLC | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| Bellevue Asset Management, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Optima Capital LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Vanguard Group Inc | – | – | – | – | Not filed |
| Norges Bank | – | – | – | – | Not filed |
| Comerica Bank | – | – | – | – | Not filed |
| Sandia Investment Management LP | – | – | – | – | Not filed |
| CIBC Private Wealth Group, LLC | – | – | – | – | Not filed |
| Global Retirement Partners, LLC | – | – | – | – | Not filed |
| ORG Partners LLC | – | – | – | – | Not filed |